Market Cap
$2.25 B
-$66.89 M-2.89%
Fri, 29 Nov 2024 19:23:08 GMT
Summary:
Ligand Pharmaceuticals Incorporated market capitalization is currently $2.25 billion, with a fall of -$66.89 million (-2.89%) during the most recent trading day. Over the past year, it has increased by +$1.20 billion (+114.13%). LGND market cap is now -61.18% below its all-time high of $5.79 billion.LGND Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | -2.9% | -2.9% | +0.7% | - |
| 1 m1 month | -0.0% | -0.7% | - | - |
| 3 m3 months | +16.3% | +12.4% | - | - |
| 6 m6 months | +48.5% | +41.2% | - | - |
| ytdytd | +79.2% | +66.5% | - | - |
| 1 y1 year | +114.1% | +97.6% | +8.5% | - |
| 5 y5 years | +13.3% | +5.3% | +7.6% | - |
LGND Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $2.49 B | -9.8% | $1.98 B | +13.4% |
| 3 m | 3 months | $2.49 B | -9.8% | $1.78 B | +26.4% |
| 6 m | 6 months | $2.49 B | -9.8% | $1.40 B | +60.9% |
| 1 y | 1 year | $2.49 B | -9.8% | $1.02 B | +120.7% |
| 3 y | 3 years | $2.72 B | -17.4% | $864 M | +160.4% |
| 5 y | 5 years | $3.47 B | -35.2% | $864 M | +160.4% |
| alltime | all time | $5.79 B | -61.2% | $102 M | +2094.6% |
Ligand Pharmaceuticals Incorporated Market Cap History
| Date | Value |
|---|---|
| 2024 | $2.25 B(+79.1%) |
| 2023 | $1.26 B(+10.9%) |
| 2022 | $1.13 B(-56.3%) |
| 2021 | $2.59 B(+61.9%) |
| 2020 | $1.60 B(-8.9%) |
| 2019 | $1.75 B(-37.7%) |
| 2018 | $2.82 B(-2.7%) |
| 2017 | $2.90 B(+36.3%) |
| 2016 | $2.12 B(-1.8%) |
| 2015 | $2.16 B(+107.6%) |
| 2014 | $1.04 B(-3.3%) |
| 2013 | $1.08 B(+144.0%) |
| 2012 | $441.32 M(+90.0%) |
| 2011 | $232.23 M(+33.4%) |
| 2010 | $174.02 M(-31.3%) |
| Date | Value |
|---|---|
| 2009 | $253.16 M(-2.7%) |
| 2008 | $260.14 M(-42.9%) |
| 2007 | $455.37 M(-58.2%) |
| 2006 | $1.09 B(+33.7%) |
| 2005 | $814.65 M(-4.1%) |
| 2004 | $849.38 M(-21.0%) |
| 2003 | $1.08 B(+180.2%) |
| 2002 | $383.68 M(-64.3%) |
| 2001 | $1.08 B(+35.4%) |
| 2000 | $794.50 M(+16.4%) |
| 1999 | $682.60 M(+28.5%) |
| 1998 | $531.13 M(+7.1%) |
| 1997 | $495.73 M(+4.8%) |
| 1996 | $473.01 M(+145.1%) |
| 1995 | $193.00 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
- What is LGND market capitalization year-to-date change?
- What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
What is Ligand Pharmaceuticals Incorporated market capitalization?
The current market cap of LGND is $2.25 B
What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high market capitalization is $5.79 B
What is LGND market capitalization year-to-date change?
Ligand Pharmaceuticals Incorporated market capitalization has changed by +$993.49 M (+79.15%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, LGND market capitalization has changed by +$1.20 B (+114.13%)